research funding database


Multiple Sclerosis Research Program – Clinical Trial Award (worldwide)

Share this post

funding consultation boking
Free trial

The Multiple Sclerosis Research Program – Clinical Trial Award from the Congressionally Directed Medical Research Programs (CDMRP) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of multiple sclerosis. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first-in-human, phase 0) to demonstrate the feasibility or inform the design of more advanced trials, through large-scale trials to determine efficacy in relevant patient populations. The program is open to researchers in the USA and worldwide.

The award provides up to 2 million USD over 3 years. Indirect costs may be covered.

Funding Opportunity Number: HT942524MSRPCTA

Pre-Application Submission Deadline: 5:00 p.m. Eastern time (ET), June 10, 2024.

Application Submission Deadline: 11:59 p.m. ET, October 7, 2024.

Adverts. Premium members do not see Google Ads.

Please Login / Subscribe to our premium membership to see the content. Sign up to Free trial to see detailed funding information.

non member

We value your opinion

Complete our 1-min user survey and receive complimentary full access to our premium research funding database.

Sign-up for our monthly
research funding newsletter

you can unsubscribe at any time